Diversion Control Homepage Diversion Control Homepage Privacy Policy Contact Us What's New Hot Items Site Map Search Diversion SiteDEA Diversion Control Program Logo and Banner

Federal Register Notices > Notices of Application - 2003 > Chattem Chemicals, Inc.

Notices of Application - 2003



[Federal Register: April 15, 2003 (Volume 68, Number 72)]
[Notices]
[Page 18261-18262]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15ap03-102]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to section 1301.33(a) of title 21 of the Code of Federal Regulations (CFR), this is notice that on May 13, 2002, Chattem Chemicals, Inc., 3801 St.

[[Page 18262]]

Elmo Avenue, Building 18 Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substance listed below:

Drug  Schedule
N-Ethylamphetamine (1475) I
4-Methoxyamphetamine (7411) I
2,5-Dimethoxyamphetamine (7396) I
Difenoxin (9168) I
Amphetamine (1100) II
Methamphetamine (1105) II
Pentobarbital (2270) II
Methylphenidate (1724) II
Secobarbital (2315) II
Meperidine (9230) II
Codeine (9050) II
Oxycodone (9143) II
Diphenoxylate (9170) II
Hydrocodone (9193) II
Morphine (9300) II
Thebaine (9333) II
Alfentanil (9737) II
Sufentanil (9740) II
Fentanyl (9801) II
Dextropropoxyphene (9273) II

The firm plans to bulk manufacture the listed controlled substances to produce products for distribution to its customers.

Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCD), and must be filed no later than 60 days from publication.

Dated: April 3, 2003.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 03-9228 Filed 4-14-03; 8:45 am]
BILLING CODE 4410-09-M

NOTICE: This is an unofficial version. An official version of these publications may be obtained directly from the Government Printing Office (GPO).

Back to Top


Registration Support  
Toll Free Number: 1-800-882-9539

ARCOS
| Career Opportunities | Chemical Program | Controlled Substance Schedules | Drugs and Chemicals of Concern  
Electronic Commerce Initiatives |  | Federal Register Notices | Import Export | Links | Meetings and Events | NFLIS
Offices & Directories | On-Line Forms & Applications | Program DescriptionPublications | Questions & Answers | Quotas  
  Reports Required by 21 CFR | Title 21 Regulations & Codified CSA
   Contact Us | HomeHot Items | Site Map | Search | What's New